Autolus Announces Pricing of Initial Public Offering | Lao Tribune

Autolus Announces Pricing of Initial Public Offering

Autolus Announces Pricing of Initial Public Offering

LONDON – 22 June, 2018 – Autolus Therapeutics plc (“Autolus”), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the pricing of its initial public offering in the United States